Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012
Risperidone, Haloperidol, and Placebo in the Treatment of Aggressive Challenging Behaviour in Patients With Intellectual Disability: A Randomised Controlled Trial
Lancet 371:57-63,9, Tyrer,P.,et al, 2008
Objective Changes in Motor Function During Placebo Treatment in PD
Neurol 54:710-714, Goetz,C.G.,et al, 2000
Ethical Use of Placebos and Provocative Testing in Diagnosing Nonepileptic Seizures
Neurol 47:866-870, Devinsky,O.&Fisher,R., 1996
Utility and Reliability of Placebo Infusion in the Evaluation of Patients with Seizures
neurol 44:394-399, Walczak,T.S.,et al, 1994